Precise, markerless single-base substitutions in yeast using CRISPR nickase-mediated deaminase technology.
Our base editing service enables targeted point mutations in Saccharomyces cerevisiae without double-strand breaks or donor templates, streamlining metabolic engineering and functional genomics applications.
Leveraging a CRISPR nickase fused to a cytidine or adenosine deaminase, we achieve targeted single-base transitions with high accuracy and minimal off-target effects.
We analyze your target region and design a high-specificity guide RNA. The nickase-deaminase fusion and guide expression cassette are cloned into a yeast vector for transformation.
The construct is transformed into S. cerevisiae via chemical methods. After selection, colonies are screened by PCR and Sanger sequencing to confirm the intended base change. A purified, verified clone is archived and delivered.
Custom guide RNAs are designed to minimize off-target binding and evaluate on-target efficiency, using proprietary algorithms.
We assemble a plasmid encoding the nickase-deaminase fusion and the guide RNA expression cassette, tailored to your strain.
Every edited clone is verified by Sanger sequencing spanning the target site to confirm the intended single-base change and absence of unwanted mutations.
Each project delivers a verified edited S. cerevisiae strain along with project documentation of the editing process and QC results.
Each project is customized to your target gene and strain. Typical parameters are described below; final scope is defined in the statement of work.
| Parameter | Typical project scope |
|---|---|
| Host Strain | Any S. cerevisiae strain supplied by client or our standard laboratory strain (e.g., BY4741). |
| Editing Type | Single C→T (cytidine base editor) or A→G (adenine base editor) substitution. |
| Guide RNA Design | Scoped per project after consultation |
| Construct | Nickase-deaminase fusion expression plasmid with guide RNA cassette, assembled in-house. |
| Transformation Method | LiAc/SS carrier DNA/PEG chemical transformation. |
| Selection | Auxotrophic or drug marker if required; markerless editing available (no selection scar). |
| Screening Depth | Typically 4–8 colonies per target screened by colony PCR and Sanger sequencing. |
| Clone Purification | Single-colony isolation and re-streaking for purity. |
| Cryopreservation | Archived glycerol stock of verified edited strain. |
A structured five-step process from target selection to delivery of your verified base-edited yeast strain.
We analyze your target genomic region and design a guide RNA with high specificity. The guide sequence is optimized to minimize off-target binding and evaluate on-target editing efficiency.
A base editing plasmid is assembled by cloning the nickase-deaminase fusion (CBE or ABE) and guide RNA expression cassette into a yeast vector. The construct is verified by restriction digestion and sequencing.
The plasmid is introduced into S. cerevisiae using a standard lithium acetate/single-stranded carrier DNA/PEG protocol. Transformants are plated on selective medium and incubated until colonies appear.
Individual colonies are picked, the target genomic region is PCR-amplified, and Sanger sequencing is performed to confirm the intended base change. Editing efficiency is recorded per project.
A verified single colony is re-streaked for purity, archived as a glycerol stock, and shipped along with the base editing plasmid, sequencing data, and a detailed QC report.
Targeted single-base changes in S. cerevisiae enable precise functional studies and metabolic pathway optimization.
Introduce point mutations in rate-limiting enzymes or regulatory proteins to evaluate flux toward desired metabolites.
Generate allelic series or test specific missense mutations to dissect protein function and cellular pathways.
Create point mutations to probe active sites, binding interfaces, or stability determinants in yeast-expressed proteins.
Common questions about service scope, QC, and technical considerations for base editing in S. cerevisiae.
We offer both cytidine base editing (C→T) and adenine base editing (A→G). These conversions are achieved by fusing a nickase Cas9 with a cytidine deaminase or adenosine deaminase, respectively. The target must be within a suitable PAM-proximal window, typically positions 4–8 of the protospacer. Our design team evaluates each target and selects the appropriate editor.
Editing efficiency is determined by Sanger sequencing of individual colonies after transformation. We typically screen 4–8 colonies per target and report the proportion that carry the intended base change. Efficiency varies with target locus, guide RNA design, and strain background; please consult our team for typical expectations.
QC includes Sanger sequencing of the target region from the purified clone to confirm the intended base change and absence of unwanted indels. The editing plasmid is sequenced at construction. A final QC report documents the base change, chromatogram, strain purity, and cryopreservation details.
Base editing can edit multiple genome copies, but efficiency may be lower for polyploid strains due to the need to edit all alleles. We recommend discussing your specific strain ploidy with our project managers to design an appropriate screening strategy. Markerless editing is still feasible when multiple alleles contain the target sequence.
Get a customized quote for your Saccharomyces cerevisiae Base Editing project. Our experts will respond within 24 hours.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.